» Articles » PMID: 7836436

Contribution of Aromatic Moieties of Tyrosine 133 and of the Anionic Subsite Tryptophan 86 to Catalytic Efficiency and Allosteric Modulation of Acetylcholinesterase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Feb 3
PMID 7836436
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Substitution of Trp-86, in the active center of human acetylcholinesterase (HuAChE), by aliphatic but not by aromatic residues resulted in a several thousandfold decrease in reactivity toward charged substrate and inhibitors but only a severalfold decrease for noncharged substrate and inhibitors. The W86A and W86E HuAChE enzymes exhibit at least a 100-fold increase in the Michaelis-Menten constant or 100-10,000-fold increase in inhibition constants toward various charged inhibitors, as compared to W86F HuAChE or the wild type enzyme. On the other hand, replacement of Glu-202, the only acidic residue proximal to the catalytic site, by glutamine resulted in a nonselective decrease in reactivity toward charged and noncharged substrates or inhibitors. Thus, the quaternary nitrogen groups of substrates and other active center ligands, are stabilized by cation-aromatic interaction with Trp-86 rather than by ionic interactions, while noncharged ligands appear to bind to distinct site(s) in HuAChE. Analysis of the Y133F and Y133A HuAChE mutated enzymes suggests that the highly conserved Tyr-133 plays a dual role in the active center: (a) its hydroxyl appears to maintain the functional orientation of Glu-202 by hydrogen bonding and (b) its aromatic moiety maintains the functional orientation of the anionic subsite Trp-86. In the absence of aromatic interactions between Tyr-133 and Trp-86, the tryptophan acquires a conformation that obstructs the active site leading, in the Y133A enzyme, to several hundredfold decrease in rates of catalysis, phosphorylation, or in affinity to reversible active site inhibitors. It is proposed that allosteric modulation of acetylcholinesterase activity, induced by binding to the peripheral anionic sites, proceeds through such conformational change of Trp-86 from a functional anionic subsite state to one that restricts access of substrates to the active center.

Citing Articles

Model acetylcholinesterase-Fc fusion glycoprotein biotechnology system for the manufacture of an organophosphorus toxicant bioscavenging countermeasure.

Biel T, Faison T, Matthews A, Ortega-Rodriguez U, Falkowski V, Meek E Bioeng Transl Med. 2024; 9(5):e10666.

PMID: 39553427 PMC: 11561780. DOI: 10.1002/btm2.10666.


Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors.

Kratky M, Stepankova S, Konecna K, Svrckova K, Maixnerova J, Svarcova M Pharmaceuticals (Basel). 2021; 14(12).

PMID: 34959630 PMC: 8704707. DOI: 10.3390/ph14121229.


Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability.

Goldenzweig A, Goldsmith M, Hill S, Gertman O, Laurino P, Ashani Y Mol Cell. 2016; 63(2):337-346.

PMID: 27425410 PMC: 4961223. DOI: 10.1016/j.molcel.2016.06.012.


Development of organophosphate hydrolase activity in a bacterial homolog of human cholinesterase.

Legler P, Boisvert S, Compton J, Millard C Front Chem. 2014; 2:46.

PMID: 25077141 PMC: 4100338. DOI: 10.3389/fchem.2014.00046.


Acetylshikonin, a Novel AChE Inhibitor, Inhibits Apoptosis via Upregulation of Heme Oxygenase-1 Expression in SH-SY5Y Cells.

Wang Y, Pan W, Liang W, Law W, Ip D, Ng T Evid Based Complement Alternat Med. 2013; 2013:937370.

PMID: 24302971 PMC: 3835493. DOI: 10.1155/2013/937370.